News Release

Chi Longevity embraces Deep Longevity's Blood Aging Clock to illuminate the path to youthful longevity

Business Announcement

Deep Longevity Ltd

Deep Longevity and Chi Longevity Partnership

image: Chi Longevity embraces Deep Longevity's Blood Aging Clock to Illuminate the Path to Youthful Longevity view more 

Credit: Deep Longevity

Chi Longevity, a leading innovator in the field of longevity research and anti-aging solutions, proudly announces its strategic partnership with Deep Longevity, a pioneering company specializing in AI powered aging clocks. Chi Longevity will use Deep Longevity’s Blood Aging Clock extensively to measure the biological age of its clients. 

Deep Longevity's Blood Age Clock uses AI to predict a person’s biological age based on 45 standard biomarkers. The Blood Age Clock will offer valuable insights into the aging process, enabling Chi Longevity to develop targeted interventions that promote healthier aging and extend human lifespan. 

“We are excited to partner with Deep Longevity to offer our clients the most accurate and up-to-date information about their biological age,” said  , CEO/CTO of Chi Longevity. “This information can be used to help our clients make informed decisions about their health and longevity.” 

 

The partnership with Deep Longevity is part of Chi Longevity’s commitment to providing its clients with the most comprehensive and effective longevity solutions. The company offers a variety of other services, including personalized nutrition plans, fitness programs, and access to cutting-edge research. 

Deepankar Nayak, CEO of Deep Longevity, added, "We are excited to partner with Chi Longevity, a visionary company dedicated to pushing the boundaries of anti-aging research. By combining our advanced AI algorithms with Chi Longevity's expertise, we have the potential to deliver precise and personalized solutions that can enhance the quality of life for individuals. Together, we will pave the way for a future where aging is no longer seen as an inevitability, but rather as a modifiable process." 

Chi Longevity and Deep Longevity are optimistic about the far-reaching impact of their collaboration on the field of longevity research and the well-being of individuals worldwide. Through their shared commitment to scientific rigor and innovation, , they aim to unlock new frontiers in anti-aging interventions that will shape the future of healthcare. 

About Chi Longevity 

Chi Longevity is a leading provider of longevity solutions. The company offers a variety of services, including personalized nutrition plans, fitness programs, and access to cutting-edge research. Chi Longevity is committed to providing its clients with the most comprehensive and effective longevity solutions. 

About Deep Longevity 

Deep Longevity is a subsidiary of Regent Pacific, a publicly traded Hong Kong Company (HKEX:0575), is a pioneer in AI-driven longevity science, specialising in developing deep aging clocks and longevity biomarkers. By harnessing the power of artificial intelligence and extensive data analysis, Deep Longevity aims to extend healthy human lifespans, optimise preventive care, and enable individuals to make informed decisions about their well-being


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.